Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on 4 Chloro 3 Hydroxybutyronitrile. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN111875520A reveals a salt-free synthesis route for Atorvastatin intermediates, offering high purity and reduced environmental costs for pharmaceutical manufacturers.
Patent CN100408555C reveals a high-yield synthesis of 4-chloro-3-hydroxybutyronitrile using basic catalysts, offering significant cost reduction and waste minimization for supply chains.